Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management
about
Anti-nerve growth factor in pain management: current evidenceBone cancer pain: from mechanism to therapyNeurotrophins and Neuropathic Pain: Role in PathobiologyMolecular signatures of mouse TRPV1-lineage neurons revealed by RNA-Seq transcriptome analysis.A Novel Small Molecule GDNF Receptor RET Agonist, BT13, Promotes Neurite Growth from Sensory Neurons in Vitro and Attenuates Experimental Neuropathy in the Rat.Small-molecule modulation of neurotrophin receptors: a strategy for the treatment of neurological disease.Vitamin D and Pain: Vitamin D and Its Role in the Aetiology and Maintenance of Chronic Pain States and Associated ComorbiditiesDiscovery and preclinical characterization of novel small molecule TRK and ROS1 tyrosine kinase inhibitors for the treatment of cancer and inflammation.Activation of cannabinoid receptor 1 inhibits increased bladder activity induced by nerve growth factor.Vitamin D Deficiency and Pain: Clinical Evidence of Low Levels of Vitamin D and Supplementation in Chronic Pain StatesA Mechanism-Based Approach to the Management of Osteoarthritis PainUse of a novel high-resolution magnetic resonance neurography protocol to detect abnormal dorsal root Ganglia in Sjögren patients with neuropathic pain: case series of 10 patients and review of the literature.Amitriptyline protects against TNF-α-induced atrophy and reduction in synaptic markers via a Trk-dependent mechanismTargeting VEGF and Its Receptors for the Treatment of Osteoarthritis and Associated Pain.Upregulation of Vanilloid Receptor-1 in Functional Dyspepsia With or Without Helicobacter pylori Infection.Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device.Secreted herpes simplex virus-2 glycoprotein G alters thermal pain sensitivity by modifying NGF effects on TRPV1.Osteoarthritis: toward a comprehensive understanding of pathological mechanism.Pain hypersensitivity mechanisms at a glanceCurcumin: a novel therapeutic for burn pain and wound healing.The TFOS International Workshop on Contact Lens Discomfort: report of the subcommittee on neurobiology.ATP P2X3 receptors and neuronal sensitization.Neurotrophins, endocannabinoids and thermo-transient receptor potential: a threesome in pain signalling.New investigational drugs for the treatment of neuropathic pain.Neuronal calcium signaling in chronic pain.Cerebrospinal Fluid Cytokines and Neurotrophic Factors in Human Chronic Pain Populations: A Comprehensive Review.Mechanism and therapeutic effectiveness of nerve growth factor in osteoarthritis painThe Challenges of Interstitial Cystitis: Current Status and Future Prospects.Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 - Part II.Cough reflex hypersensitivity: A role for neurotrophins.Analgesia via blockade of NGF/TrkA signaling does not influence fracture healing in mice.Systems Pharmacology of the NGF Signaling Through p75 and TrkA Receptors.Nerve growth factor pretreatment inhibits lidocaine‑induced myelin damage via increasing BDNF expression and inhibiting p38 mitogen activation in the rat spinal cord[EXPRESS] Monoclonal antibodies for chronic pain: a practical review of mechanisms and clinical applications.Immunohistochemical localization of nerve growth factor, tropomyosin receptor kinase A, and p75 in the bone and articular cartilage of the mouse femur.Fibrin-based microsphere reservoirs for delivery of neurotrophic factors to the brain.Effects of kinesiologic taping on epidermal-dermal distance, pain, edema and inflammation after experimentally induced soft tissue trauma.Physiologic facet capsule stretch can induce pain & upregulate matrix metalloproteinase-3 in the dorsal root ganglia when preceded by a physiological mechanical or nonpainful chemical exposure.Impaired glyoxalase activity is associated with reduced expression of neurotrophic factors and pro-inflammatory processes in diabetic skin cells.Effect of orexin-A (hypocretin-1) on hyperalgesic and cachectic manifestations of experimentally induced rheumatoid arthritis in rats.
P2860
Q26746194-08DD2F4A-B7E0-4427-A2EE-0C78D33EFCFDQ27025262-28513D3E-65A0-43C9-930D-23A19811EE8AQ28084413-EE41854C-F82B-4B2C-A1C9-5A9551E9E4ABQ33792431-A1CC6880-D56D-4894-BEC1-61E97C186F90Q33819340-58E6FAAE-727A-438F-8ED0-719BC5D374CDQ34366768-B50C5991-FB3B-4B26-8E35-8FA72707CDBFQ34481412-70C9E424-F3DE-4AA0-8734-5675BEBE9672Q35080328-E5197562-3C7F-405F-9481-86F2339FDCCDQ35116257-6928C6DB-CF3F-45DA-BB38-4FE1B947034AQ35752542-357EC319-8C96-4D10-A8C7-08EC1E85E269Q36217637-2B3B71E4-F4DF-4752-8656-8BF578675D11Q36247817-67CBF667-31F8-44B7-BBA0-B001625CC816Q36719650-DEDC98DD-94F8-40CF-A1B8-308A6A07240BQ36890872-D4A888D2-7832-46D0-8F9C-BE096EB3CC3FQ36993340-98E9E8EE-954B-4F11-A696-F02F8C0BE0F7Q37073096-3B9544EC-064B-438E-95B9-C9F4C81BAB9FQ37221265-A3499A8B-CAAC-4B6F-B8BF-AB4856DDD5A0Q37588803-7F6071FF-104A-4C7E-92DE-0BB971E926CAQ38119457-8ECE3DC4-141B-42F8-A359-76CAA5570C5CQ38125521-16E6713D-60C6-45C4-A932-B912BC134785Q38140831-A3F8B8B8-979F-41A5-B7B8-A6A59FC846C2Q38173358-039CCA9B-17A9-4DE5-91B9-603924E00CFCQ38185067-D9F1207A-4C64-4F4C-895E-7413ABCBFF9FQ38217614-FE75062F-6BE6-41C3-A9FF-284A1BACC76EQ38228215-7C48CB07-4B8F-4382-8987-F57622257A8AQ38263540-0DECE5EC-5F77-4CCA-A066-48D82645795AQ38641435-BE4F1BA5-3FF6-4A25-BDFD-BB1A6A4D36C9Q38939006-BE8B9650-B3F7-46CB-A1B6-0CA7BA4F93F9Q39166808-BE35803C-BC65-486A-8406-C1D5A467F56EQ39298750-026DAB95-AD84-464C-BD78-593C5BFBD133Q41069496-23EFA859-024B-4DDC-9BC9-F93C7C9E5F5CQ42110905-349ADCDE-5054-41B1-BFEE-A061ED10C197Q42679174-84721F23-6865-46A1-ABFC-544F372A8A51Q46156381-64C7AAFB-44C4-4C85-976F-D130282E496CQ47111283-A8F5E0DD-0F94-45D8-9B50-7186CC5CE9C3Q48258997-37BCAF23-2E85-4375-A91C-2DB3D5107C02Q50968853-D20B117A-DEC5-4DB5-8F42-502E1F04430DQ52663819-FD553172-2B63-4DC1-A49F-39764A924ECBQ53598606-AECF597A-8C12-43D3-BBE9-7857DFEB0C2DQ53829410-F6F08AB0-EAD6-414F-AF6E-EB45604A3555
P2860
Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Nerve growth factor-mediated r ...... es in clinical pain management
@ast
Nerve growth factor-mediated r ...... es in clinical pain management
@en
Nerve growth factor-mediated r ...... es in clinical pain management
@nl
type
label
Nerve growth factor-mediated r ...... es in clinical pain management
@ast
Nerve growth factor-mediated r ...... es in clinical pain management
@en
Nerve growth factor-mediated r ...... es in clinical pain management
@nl
prefLabel
Nerve growth factor-mediated r ...... es in clinical pain management
@ast
Nerve growth factor-mediated r ...... es in clinical pain management
@en
Nerve growth factor-mediated r ...... es in clinical pain management
@nl
P2860
P3181
P356
P1476
Nerve growth factor-mediated r ...... es in clinical pain management
@en
P2093
George D Shorten
Laura McKelvey
P2860
P304
P3181
P356
10.1111/JNC.12093
P407
P577
2013-02-01T00:00:00Z